Drugs / Sabin Inactivated Poliovirus Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03902054 | Dec 2017 → May 2018 | postpoliomyelitis syndrome | Jiangsu Province Centers for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sabin Inactivated Poliovirus Vaccine | “Sabin Inactivated Poliovirus Vaccine (sIPV)” NCT03902054 ↗ |
| Known as | sIPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03902054 ↗ |
| Modality | Vaccine | “Sabin Inactivated Poliovirus Vaccine (sIPV)” NCT03902054 ↗ |
| Route | Intramuscular | “Three intramuscular injections of the investigational vaccine(0.5 ml)” NCT03902054 ↗ |